Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

A 12-month prospective study of gasserian ganglion stimulation for trigeminal neuropathic pain STEREOTACTIC AND FUNCTIONAL NEUROSURGERY Machado, A., Ogrin, M., Rosenow, J. M., Henderson, J. M. 2007; 85 (5): 216-224

Abstract

Trigeminal neuropathic pain is a broad diagnostic category that includes pain of several etiologies and excludes trigeminal neuralgia. The authors report a prospective series of percutaneous gasserian ganglion stimulation for trigeminal neuropathic pain.Patients who experienced >50% reduction in pain from a 7- to 10-day trial period underwent permanent implantation and were prospectively followed.Eight of 10 trialed patients received a permanent implant. At the 12-month follow-up, 2 patients had been explanted and 1 was lost to follow-up. Three (all working at that the time) continued to experience >50% improvement in pain.The results in this series were variable but 3 patients showed long-term improvements. Patients who continued to work responded better to treatment.

View details for DOI 10.1159/000103260

View details for Web of Science ID 000248238000003

View details for PubMedID 17534134